108883 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
CAVIAR POLYPEPTIDES
#2PREPARATION METHOD FOR CORN SUPEROXIDE DISMUTASE
#3BACTERIAL SUPEROXIDE DISMUTASES
#4SALT TOLERANT PLANTS
#5TARGETING NANOENZYME FOR MITIGATING CHEMOTHERAPY-INDUCED CARDIOTOXICITY, PREPARATION METHOD
#6ARTIFICIAL BLOOD SUBSTITUTES
#7COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS
#8PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#9Products and Methods for Treatment of Amyotrophic Lateral Sclerosis
#10TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#11MICROORGANISMS AND METHODS FOR THE CONTINUOUS PRODUCTION OF FATTY ACIDS, FATTY ALCOHOLS, AND CULTURED PROTEIN FROM C1 SUBSTRATES
#12ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING HYDROCARBON CHAINS
#13SUPEROXIDE DISMUTASE 1 VARIANT AND METHOD FOR PRODUCING GLUTATHIONE OR DERIVATIVE THEREOF, USING SAME
#14Tethering Cysteine Residues Using Cyclic Disulfides
#15Products and Methods for Treatment of Amyotrophic Lateral Sclerosis
#16METHOD AND SYSTEM FOR SIMULTANEOUSLY EXTRACTING POLYSACCHARIDES, POLYPHENOLS, SOD AND VC OF ROSA ROXBURGHII TRATT FROM ROSA ROXBURGHII TRATT POMACE
#17Human Anti-SOD1 Antibodies
#18SUPEROXIDE DISMUTASE 1 (SOD1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SUPEROXIDE DISMUTASE 1- (SOD1-) ASSOCIATED NEURODEGENERATIVE DISEASES
#19IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#20Chemically Defined Serum Albumin Substitutes
#21FUSION PROTEIN FOR BACTERIAL SURFACE DISPLAY
#22Bacterial Superoxide Dismutases
#23COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#24SUPEROXIDE DISMUTASE COMPOSITIONS AND METHODS
#25COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION
#26Joint Health Composition and Use Thereof in Healthy Mammals
#27IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#28BICOMPATIBLE PEPTIDEBIOCOMPATIBLE PEPTIDES FOR INHIBITION OF AGGREGATION OF B-AMYLOID PROTEIN
#29COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND HORMONE THERAPY AGENT
#30TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#31IN-SERIES SYNTHETIC RECEPTOR AND-GATE CIRCUITS FOR EXPRESSION OF A THERAPEUTIC PAYLOAD BY ENGINEERED CELLS
#32Preparation method of high-stability superoxide dismutase with transmembrane capability
#33Baculovirus Of Recombinant Superoxide Dismutase Gene, Preparation And Application Thereof
#34IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#35Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseases
#36Paramyxovirus virus-like particles as protein delivery vehicles
#37Human Anti-SOD1 Antibodies
#38REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS
#39REDOX ENZYMES IN ANIMAL FEED COMPOSITIONS
#40USE OF A MANGANESE SUPEROXIDE DISMUTASE WITH HIGH STABILITY IN THE PREVENTION OR TREATMENT OF CEREBRAL STROKE
#41PARAMYXOVIRUS VIRUS-LIKE PARTICLES AS PROTEIN DELIVERY VEHICLES
#42Tethering cysteine residues using cyclic disulfides
#43SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE
#44GENE THERAPY FOR OXIDATIVE STRESS
#45Importation of mitochondrial protein by an enhanced allotopic approach
#46COMPOSITIONS AND METHODS FOR CELL CULTURE
#47Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis
#48Transdermal peptide with nuclear localization ability and use thereof
#49Acute Respiratory Distress Syndrome Therapeutic Agent
#50TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES
#51Tethering cysteine residues using cyclic disulfides
#52IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#53SUPEROXIDE DISMUTASE GENE AND ITS CODING PROTEIN
#54Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#55Transdermal peptide with nuclear localization ability and use thereof
#56Paramyxovirus virus-like particles as protein delivery vehicles
#57Human anti-SOD1 antibodies
#58FRUIT AND VEGETABLE JUICE RICH IN SOD AND PROCESSING METHOD THEREOF
#59COMPOSITIONS AND METHODS FOR DETECTION OF BETA N METHYLAMINO L ALANINE IN CU ZN SUPEROXIDE DISMUTASE 1
#60Materials and methods for detection and quantification of β-N-methylamino-L-alanine
#61Products and methods for treatment of familial amyotrophic lateral sclerosis
#62Combined treatment for nerve injuries
#63Method of Preparation of SOD Hydrolysates Powder
#64Microparticles for cell disruption and/or biomolecule recovery
#65Method for genetic treatment using the AAV-XBP1s/GFP virus and use thereof in the prevention and treatment of amyotrophic lateral sclerosis
#66Transgenic expression of archaea superoxide reductase
#67IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#68Acute Respiratory Distress Syndrome Therapeutic Agent
#69Tethering cysteine residues using cyclic disulfides
#70Tethering cysteine residues using cyclic disulfides
#71Method for obtaining a biomass of a microalga of the species enriched in superoxide dismutase (SOD)
#72METHODS AND COMPOSITIONS TO TREAT AND DETECT MISFOLDED-SOD1 MEDIATED DISEASES
#73Method for Obtaining a Superoxide Dismutase (SOD)-Concentrated Protein Extract
#74Mixture of Purified SODs of Plant Origin
#75COMPOSITIONS AND METHODS FOR IMPROVED PROTEIN PRODUCTION
#76Paramyxovirus virus-like particles as protein delivery vehicles
#77COMPOSITIONS AND METHODS FOR CELL CULTURE
#78TERMITE SUPEROXIDE DISMUTASES AND GLUTATHIONE PEROXIDASES FOR BIOMASS CONVERSION
#79Tethering cysteine residues using cyclic disulfides
#80Manganese superoxide dismutase variants and uses thereof
#81HEXAPEPTIDE AND USES THEREOF
#82Microparticles for cell disruption and/or biomolecule recovery
#83Adsorbent composition and use thereof
#84Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis
#85Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#86Human anti-SOD1 antibodies
#87Transgenic Expression Of Archaea Superoxide Reductase
#88Methods and systems for predicting misfolded protein epitopes
#89COMPOSITION FOR STABILIZING EC-SOD AND METHOD OF STABILIZING EC-SOD USING THE SAME
#90HUMAN-DERIVED MUTANTS OF THE dSOD1 GENE IN DROSOPHILA AND METHODS OF MAKING AND USING
#91Mitochondria targeting peptide
#92CYLINDRINS AS ETIOLOGIC AGENTS OF AMYLOID DISEASES
#93Tethering cysteine residues using cyclic disulfides
#94IMPORTATION OF MITOCHODRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#95MONOATOMIC POINT MUTANT ARTIFICIAL OXIDOREDUCTASES
#96Cell-penetrating fusion protein for regenerating or proliferating stem cell
#97Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#98Use of EC-SOD for treating angiogenesis-mediated eye diseases
#99Genetically inducible hydrogen peroxide resistance and production
#100Human anti-SOD1 antibodies
#101Nucleic acid encoding superoxide dismutase variants and methods of use thereof
#102Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#103Metal abstraction peptide with superoxide dismutase activity
#104Polyethylene glycolated superoxide dismutase mimetics
#105METHOD FOR INCREASING THE ACTIVITY OF SUPEROXIDE DISMUTASE
#106POLYETHYLENE GLYCOLATED SUPEROXIDE DISMUTASE MIMETICS
#107NOVEL EXPRESSION VECTOR
#108Cross-Linking of Superoxide Dismutase Monomers
#109CONSTRUCTS FOR DELIVERY OF THERAPEUTIC AGENTS TO NEURONAL CELLS
#110Superoxide dismutase variants and methods of use thereof
#111NOVEL USE OF EC-SOD AND METHOD FOR PREPARING THEREOF
#112Method of cloning stable stress tolerant superoxide dismutase using universal primers
#113Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#114Mutant human superoxide dismutase 1 variants
#115METHODS OF ENHANCING THE IMMUNOGENICITY OF MYCOBACTERIA AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUBERCULOSIS, AND FIBROSING LUNG DISEASES
#116METHOD FOR TREATING AND PREVENTING RADIATION DAMAGE USING GENETICALLY MODIFIED MESENCHYMAL STEM CELLS
#117Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#118VETERINARY PHARMACEUTICAL FORMULACION THAT COMPRISES AN RNA RECOMBINANT PARTICLE THAT ENCODES FOR A CU/ZN SUPEROXIDE DISMUTASE PROTEIN OF RUMINANT PATHOGENIC BACTERIA AND AT LEAST ONE RNA ALPHAVIRUS BELONGING TO THE SEMLIKI FOREST VIRUS FAMILY
#119Methods and compositions comprising heat shock proteins
#120METHOD FOR TREATING OR PREVENTING RADIATION DAMAGE BY IN VIVO GENE THERAPY
#121Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of alzheimer's disease
#122Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
#123PLANT SUPEROXIDIE DISMUTASE EXPRESSION RESISTANT TO MICRO-RNA REGULATION
#124EC SOD and use thereof
#125Superoxide dismutase (SOD) gene and a method of identifying and cloning thereof
#126METHODS AND SYSTEMS FOR PREDICTING MISFOLDED PROTEIN EPITOPES
#127MANGANESE SUPEROXIDE DISMUTASE EXON 3-DELETED ISOFORMS AND NUCLEIC ACID MOLECULES ENCODING THE ISOFORMS
#128THERAPEUTIC COMPOSITION FOR INTERSTITUAL PNEUMONIA
#129Site-specific chemical modification of proteins at their N-termini, enabling the formation of homogeneous adducts
#130SUPPRESSION OF MITOCHONDRIAL OXIDATIVE STRESS
#131Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
#132USE OF SUPEROXIDE DISMUTASES IN WASHING AND CLEANING AGENTS
#133Pro-Apoptotic Bacteria and Compositions for Delivery and Expression of Antigens
#134Thermostable superoxide dismutase
#135Importation of mitochondrial protein by an enhanced allotopic approach
#136Constructs for delivery of therapeutic agents to neuronal cells
#137Herbicide resistant plants
#138Pharmaceutical compositions comprising SODs and prolamine based peptide fragments
#139Methods and compositions for treating gain-of-function disorders using RNA interference
#140Expression vectors pSSA-K and pSSA-H for expression of SOD and APX in plants to provide stress tolerance
#141Methods and compositions to treat misfolded-SOD1 mediated diseases
#142Binding peptidomimetics and uses of the same
#143Extracellular superoxide dismutase (EC-SOD) gene delivery to prevent oxidative injury
#144Type II cubic liquid crystal composition
#145EC SOD and cell transducing EC SOD and use thereof
#146THE PRODUCTION OF HIGH-ACTIVITY SUPEROXIDE DISMUTASE (SOD) AND APPLICATION IN METHODS OF BOTH THE SOLID-STATE AND LIQUID-STATE FERMENTATION
#147Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
#148Superoxide dismutase (SOD) gene and a method of identifying and cloning thereof
#149Lecithinized superoxide dismutase composition and a process for its production
#150Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof
#151Recombinant BCG strains with attenuated immunosuppressive properties
#152Screening assay based on rhe sod-3 promotor for the identification of compounds modulating akt or upstream regulators such as insulin igf-1 receptors
#153Methods and compositions for treating gain-of-function disorders using RNA interference
#154Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1
#155Delivery of superoxide dismutase to neuronal cells
#156Adenovirus including a gene coding for a superoxide dismutase
#157Manganese superoxide dimutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
#158Knockin non-human animal and tissue-specific MnSOD knockout non-human animal
#159Novel manganese superoxide dismutase regulatory elements and uses therefore
#160Selenium-containing nano HOF, antioxidant nanozyme, preparation method and application thereof
#161Method for methanol free culturing of methylotrophic yeast for the biosynthesis of added value products